Management of nausea and vomiting in patients with advanced cancer at the end of life
Amanda Webb Macmillan clinical nurse specialist, Palliative care, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Northwood, England
The prevalence of nausea and vomiting in patients with advanced cancer varies, but it generally increases towards the end of life. Nausea and vomiting can be distressing and debilitating for patients, and can affect quality of life significantly. This article discusses the assessment of nausea and vomiting, current understanding of the emetic pathways, and pharmacological management of nausea and vomiting in patients with advanced cancer at the end of life.
Nursing Standard. 32, 10,53-63. doi: 10.7748/ns.2017.e10993
Received: 24 August 2017
Accepted: 19 September 2017
Published in print: 01 November 2017Peer review
This article has been subject to external double-blind peer review and checked for plagiarism using automated softwareConflict Of Interest